Singapore’s Temasek Group, through its impact investment arm ABC Impact Fund II LP, has finalized a deal to acquire a 16% stake in Ayala Healthcare Holdings Inc. (AC Health), marking its first investment in the Philippines.
Under the agreement, ABC Impact subscribed to 121.9 million common shares and 208.28 million redeemable preferred shares of AC Health, representing the first tranche of its capital commitment. The investment will support AC Health’s expansion plans across hospitals, clinics, and retail pharmacies, combining organic growth with strategic acquisitions.
AC Health aims to operate 10 hospitals, 300 multispecialty clinics, and 1,150 pharmacies by 2027, strengthening its position as one of the Philippines’ leading integrated healthcare networks. Its portfolio includes Healthway Medical Network, Generika Drugstore, IE Medica, MedEthix, and St. Joseph Drug.
ABC Impact, part of the Temasek Trust Asset Management group, will also provide regional expertise and innovation partnerships to help AC Health tap into best practices and emerging healthcare models across Asia.
The investment follows AC Health’s recent partnership with Indonesia’s Dexa Group, which will distribute affordable medicines in the Philippines through Glorious Dexa Mandaya Philippines, further expanding the company’s reach in the pharmaceutical and healthcare distribution space.
(Source: Philippine Daily Inquirer)
